Adjuvant endocrine therapy for premenopausal women with early breast cancer

Adjuvant endocrine therapy is a pivotal component of treatment for premenopausal women with early-stage hormone receptor-positive breast cancer. Currently, the standard endocrine therapy for premenopausal women is tamoxifen; a role for ovarian suppression or ablation has also been identified. Uncert...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Ting, Davidson, Nancy E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246185/
https://www.ncbi.nlm.nih.gov/pubmed/18190722
http://dx.doi.org/10.1186/bcr1830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246185/
https://www.ncbi.nlm.nih.gov/pubmed/18190722
http://dx.doi.org/10.1186/bcr1830

Ejemplares similares